Cargando…

Mast cell activation and clinical outcome in pediatric cholelithiasis and biliary dyskinesia

BACKGROUND: The current study was undertaken to determine the degree of activation of gallbladder mucosal mast cells, whether mast cell (MC) density or activation differ between patients with and without a positive clinical response to cholecystectomy, and whether either density or activation correl...

Descripción completa

Detalles Bibliográficos
Autores principales: Friesen, Craig A, Neilan, Nancy, Daniel, James F, Radford, Kim, Schurman, Jennifer V, Li, Ding-You, Andre, Linda, St Peter, Shawn D, Holcomb, George W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224507/
https://www.ncbi.nlm.nih.gov/pubmed/21896203
http://dx.doi.org/10.1186/1756-0500-4-322
_version_ 1782217399345348608
author Friesen, Craig A
Neilan, Nancy
Daniel, James F
Radford, Kim
Schurman, Jennifer V
Li, Ding-You
Andre, Linda
St Peter, Shawn D
Holcomb, George W
author_facet Friesen, Craig A
Neilan, Nancy
Daniel, James F
Radford, Kim
Schurman, Jennifer V
Li, Ding-You
Andre, Linda
St Peter, Shawn D
Holcomb, George W
author_sort Friesen, Craig A
collection PubMed
description BACKGROUND: The current study was undertaken to determine the degree of activation of gallbladder mucosal mast cells, whether mast cell (MC) density or activation differ between patients with and without a positive clinical response to cholecystectomy, and whether either density or activation correlate with gallbladder emptying. RESULTS: Fifteen biliary dyskinesia (BD) and 13 symptomatic cholelithiasis (CL) patients undergoing cholecystectomy were prospectively enrolled. Gallbladder wall MC density (by immunohistochemistry) and activation (by electron microscopy) were determined. Clinical response was evaluated 30 days post-cholecystectomy on a 5-point Likert-type scale. A complete or nearly complete clinical response was seen in 100% of CL and in 87% of BD patients. The overall degranulation indices were 49.4 ± 18.7% for CL patients and 44.2 ± 16.8% for BD patients. Neither MC density nor activation correlated with the gallbladder ejection fraction. A complete clinical response was associated with lower epithelial MC density. CONCLUSION: Cholecystectomy is efficacious in relieving pain in both CL and BD patients. BD and CL are associated not only with increased MC density but a moderate to high degree of MC activation. A possible relationship between MC density and outcome for BD warrants further investigation.
format Online
Article
Text
id pubmed-3224507
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32245072011-11-27 Mast cell activation and clinical outcome in pediatric cholelithiasis and biliary dyskinesia Friesen, Craig A Neilan, Nancy Daniel, James F Radford, Kim Schurman, Jennifer V Li, Ding-You Andre, Linda St Peter, Shawn D Holcomb, George W BMC Res Notes Research Article BACKGROUND: The current study was undertaken to determine the degree of activation of gallbladder mucosal mast cells, whether mast cell (MC) density or activation differ between patients with and without a positive clinical response to cholecystectomy, and whether either density or activation correlate with gallbladder emptying. RESULTS: Fifteen biliary dyskinesia (BD) and 13 symptomatic cholelithiasis (CL) patients undergoing cholecystectomy were prospectively enrolled. Gallbladder wall MC density (by immunohistochemistry) and activation (by electron microscopy) were determined. Clinical response was evaluated 30 days post-cholecystectomy on a 5-point Likert-type scale. A complete or nearly complete clinical response was seen in 100% of CL and in 87% of BD patients. The overall degranulation indices were 49.4 ± 18.7% for CL patients and 44.2 ± 16.8% for BD patients. Neither MC density nor activation correlated with the gallbladder ejection fraction. A complete clinical response was associated with lower epithelial MC density. CONCLUSION: Cholecystectomy is efficacious in relieving pain in both CL and BD patients. BD and CL are associated not only with increased MC density but a moderate to high degree of MC activation. A possible relationship between MC density and outcome for BD warrants further investigation. BioMed Central 2011-09-06 /pmc/articles/PMC3224507/ /pubmed/21896203 http://dx.doi.org/10.1186/1756-0500-4-322 Text en Copyright ©2010 Friesen et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Friesen, Craig A
Neilan, Nancy
Daniel, James F
Radford, Kim
Schurman, Jennifer V
Li, Ding-You
Andre, Linda
St Peter, Shawn D
Holcomb, George W
Mast cell activation and clinical outcome in pediatric cholelithiasis and biliary dyskinesia
title Mast cell activation and clinical outcome in pediatric cholelithiasis and biliary dyskinesia
title_full Mast cell activation and clinical outcome in pediatric cholelithiasis and biliary dyskinesia
title_fullStr Mast cell activation and clinical outcome in pediatric cholelithiasis and biliary dyskinesia
title_full_unstemmed Mast cell activation and clinical outcome in pediatric cholelithiasis and biliary dyskinesia
title_short Mast cell activation and clinical outcome in pediatric cholelithiasis and biliary dyskinesia
title_sort mast cell activation and clinical outcome in pediatric cholelithiasis and biliary dyskinesia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224507/
https://www.ncbi.nlm.nih.gov/pubmed/21896203
http://dx.doi.org/10.1186/1756-0500-4-322
work_keys_str_mv AT friesencraiga mastcellactivationandclinicaloutcomeinpediatriccholelithiasisandbiliarydyskinesia
AT neilannancy mastcellactivationandclinicaloutcomeinpediatriccholelithiasisandbiliarydyskinesia
AT danieljamesf mastcellactivationandclinicaloutcomeinpediatriccholelithiasisandbiliarydyskinesia
AT radfordkim mastcellactivationandclinicaloutcomeinpediatriccholelithiasisandbiliarydyskinesia
AT schurmanjenniferv mastcellactivationandclinicaloutcomeinpediatriccholelithiasisandbiliarydyskinesia
AT lidingyou mastcellactivationandclinicaloutcomeinpediatriccholelithiasisandbiliarydyskinesia
AT andrelinda mastcellactivationandclinicaloutcomeinpediatriccholelithiasisandbiliarydyskinesia
AT stpetershawnd mastcellactivationandclinicaloutcomeinpediatriccholelithiasisandbiliarydyskinesia
AT holcombgeorgew mastcellactivationandclinicaloutcomeinpediatriccholelithiasisandbiliarydyskinesia